Clinical Study
Effects of Lactobacillus gasseri OLL2716 on Helicobacter pylori-Associated Dyspepsia: A Multicenter Randomized Double-Blind Controlled Trial
Table 3
Dyspeptic symptoms.
| Symptom | Lactobacillus gasseri group () | Placebo group () | Before, (%) | After, (%) | | Before, (%) | After, (%) | |
| Postprandial fullness | 18/61 (29.5%) | 20/61 (32.8%) | 0.696 | 31/63 (49.2%) | 24/61 (38.1%) | 0.209 | Epigastric pain | 8/61 (13.1%) | 13/61 (21.3%) | 0.230 | 21/63 (33.3%) | 27/63 (42.9%) | 0.271 | Heartburn | 17/61 (27.9%) | 17/61 (27.9%) | 1.000 | 20/63 (31.7%) | 20/63 (31.7%) | 1.000 | Nausea | 16/61 (26.2%) | 15/61 (24.6%) | 0.835 | 19/63 (30.1%) | 17/63 (27.0%) | 0.693 | Bloating | 19/61 (31.1%) | 21/61 (34.4%) | 0.700 | 25/63 (39.7%) | 29/63 (23.8%) | 0.471 |
|
|
and versus the placebo group.
|